{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:44:34Z","timestamp":1788201874655,"version":"build-2803163510"},"reference-count":38,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Nicolaus Copernicus University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Infections caused by multi-drug-resistant Acinetobacter baumannii are a global threat. The World Health Organization has recognized carbapenem-resistant A. baumannii as critical pathogens for which further research and development of effective drugs are needed. The aim of this study was to identify antibiotic combinations with possible potential for additive or synergistic action with colistin, and thus to find new therapeutic possibilities for the treatment of infections caused by multi-drug-resistant A. baumannii. The research involved the two multi-drug-resistant A. baumannii strains isolated from hospitalized patients. In this study, six antibiotics were chosen to combine with colistin: amikacin, gentamicin, ampicillin\/sulbactam, tigecycline, imipenem, and meropenem. For both strains, the synergistic activity of colistin and ampicillin\/sulbactam was demonstrated, and additive activity for ABA25, colistin, and meropenem or imipenem. The MICs of antibiotics that showed synergism with colistin were reduced by 8- to 128-fold. Additive interactions have been shown in colistin combination with carbapenems, aminoglycosides, and tigecycline. The results prove the synergistic effect of the tested antibiotics, which may be helpful in the selection of potentially effective multi-drug therapies and their application in clinical practice, which may involve reducing the doses of colistin in therapy and its toxicity.<\/jats:p>","DOI":"10.3390\/microorganisms13061206","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T20:16:22Z","timestamp":1748204182000},"page":"1206","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Salvage Therapy Against Infections of MDR Acinetobacter baumannii Achieved by Synergistic Effect of Colistin-Containing Therapies\u2014Preliminary Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1315-7194","authenticated-orcid":false,"given":"Pawe\u0142","family":"Kmiecikowski","sequence":"first","affiliation":[{"name":"Microbiology Student Science Club, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 9 Maria Sk\u0142odowska-Curie Street, 85-094 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6193-5610","authenticated-orcid":false,"given":"Aniela","family":"Gabriel","sequence":"additional","affiliation":[{"name":"Microbiology Student Science Club, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 9 Maria Sk\u0142odowska-Curie Street, 85-094 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-9778","authenticated-orcid":false,"given":"Dagmara","family":"Depka","sequence":"additional","affiliation":[{"name":"Microbiology Department, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 9 Maria Sk\u0142odowska-Curie Street, 85-094 Bydgoszcz, Poland"},{"name":"Clinical Microbiology Laboratory, Dr. Antoni Jurasz University Hospital No. 1 in Bydgoszcz, 9 Maria Sk\u0142odowska-Curie Street, 85-094 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6787-1378","authenticated-orcid":false,"given":"Tomasz","family":"Bogiel","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, Dr. Antoni Jurasz University Hospital No. 1 in Bydgoszcz, 9 Maria Sk\u0142odowska-Curie Street, 85-094 Bydgoszcz, Poland"},{"name":"Department of Propaedeutics of Medicine and Infection Prevention, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, 9 Maria Sk\u0142odowska-Curie Street, 85-094 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature10388","article-title":"Antibiotic resistance is ancient","volume":"477","author":"King","year":"2011","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ebiom.2019.03.006","article-title":"Epidemiologic and genomic insights on mcr-1-harbouring Salmonella from diarrhoeal outpatients in Shanghai, China, 2006\u20132016","volume":"42","author":"Lu","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/aphw.12345","article-title":"Behavioral determinants of antibiotic resistance: The role of social information","volume":"14","author":"Korn","year":"2022","journal-title":"Appl. Psychol. Health Well Being"},{"key":"ref_4","unstructured":"World Health Organization (2025, March 17). 2021 Antibacterial Agents in Clinical and Preclinical Development: An Overview and Analysis. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/354545\/9789240047655-eng.pdf?sequence=1."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","article-title":"Colistin and its role in the Era of antibiotic resistance: An extended review (2000\u20132019)","volume":"9","author":"Zhong","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Monsel, A., Roberts, J.A., Pontikis, K., Mimoz, O., Rello, J., Qu, J., Rouby, J.J., and on behalf of the European Investigator Network for Nebulized Antibiotics in Ventilator-Associated Pneumonia (ENAVAP) (2021). Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives. Microorganisms, 9.","DOI":"10.3390\/microorganisms9061154"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3947\/ic.2024.0055","article-title":"Optimizing Treatment for Carbapenem-Resistant Acinetobacter baumannii Complex Infections: A Review of Current Evidence","volume":"56","author":"Choi","year":"2024","journal-title":"Infect. Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Papazachariou, A., Tziolos, R.-N., Karakonstantis, S., Ioannou, P., Samonis, G., and Kofteridis, D.P. (2024). Treatment Strategies of Colistin Resistance Acinetobacter baumannii Infections. Antibiotics, 13.","DOI":"10.3390\/antibiotics13050423"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Abou Fayad, A., Haraoui, L.-P., Sleiman, A., Hussein, H., Grenier, F., Derbaj, G., Itani, D., Iweir, S., Sherri, N., and Bazzi, W. (2024). Molecular Characteristics of Colistin Resistance in Acinetobacter baumannii and the Activity of Antimicrobial Combination Therapy in a Tertiary Care Medical Center in Lebanon. Microorganisms, 12.","DOI":"10.3390\/microorganisms12020349"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Halim, J., Carr, R.A., Fliorent, R., Jonnalagadda, K., Kurbonnazarova, M., Kaur, M., Millstein, I., and Carabetta, V.J. (2024). Combinations of Antibiotics Effective against Extensively- and Pandrug-Resistant Acinetobacter baumannii Patient Isolates. Microorganisms, 12.","DOI":"10.3390\/microorganisms12071353"},{"key":"ref_11","first-page":"427","article-title":"Aktywno\u015b\u0107 lek\u00f3w przeciwdrobnoustrojowych zastosowanych w kombinacjach wobec pa\u0142eczek Gram-ujemnych w badaniach in vitro","volume":"8","author":"Szliszka","year":"2017","journal-title":"Post\u0119py Nauk. Med."},{"key":"ref_12","unstructured":"Antimicrobial Resistance Collaborators (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet, 399, 629\u2013655."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jgar.2021.01.018","article-title":"What is the optimal antibiotic treatment strategy for carbapenem-resistant Acinetobacter baumannii (CRAB)? A multicentre study in Korea","volume":"24","author":"Seok","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Karvouniaris, M., Poulakou, G., Tsiakos, K., Chatzimichail, M., Papamichalis, P., Katsiaflaka, A., Oikonomou, K., Katsioulis, A., Palli, E., and Komnos, A. (2022). ICU-Associated Gram-Negative Bloodstream Infection: Risk Factors Affecting the Outcome Following the Emergence of Colistin-Resistant Isolates in a Regional Greek Hospital. Antibiotics, 11.","DOI":"10.3390\/antibiotics11030405"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Kowalska-Krochmal, B., and Dudek-Wicher, R. (2021). The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance. Pathogens, 10.","DOI":"10.3390\/pathogens10020165"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01121-14","article-title":"When does 2 plus 2 equal 5? A review of antimicrobial synergy testing","volume":"52","author":"Doern","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_17","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2025, March 17). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Available online: https:\/\/www.megumed.de\/wp-content\/uploads\/2024\/02\/v_14.0_Breakpoint_Tables.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Oliva, A., Garzoli, S., De Angelis, M., Marzuillo, C., Vullo, V., Mastroianni, C.M., and Ragno, R. (2019). In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant Acinetobacter baumannii. Molecules, 24.","DOI":"10.3390\/molecules24050886"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Karakonstantis, S., Ioannou, P., Samonis, G., and Kofteridis, D.P. (2021). Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter baumannii. Antibiotics, 10.","DOI":"10.3390\/antibiotics10111344"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Abdul-Mutakabbir, J.C., Yim, J., Nguyen, L., Maassen, P.T., Stamper, K., Shiekh, Z., Kebriaei, R., Shields, R.K., Castanheira, M., and Kaye, K.S. (2021). In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii. Antibiotics, 10.","DOI":"10.3390\/antibiotics10070880"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Mantzana, P., Protonotariou, E., Kassomenaki, A., Arhonti, M., Meletis, G., Vasilaki, O., Kagkalou, G., and Skoura, L. (2022). In vitro Synergistic Activity of Colistin-Based Antimicrobial Combinations against Extensively Drug-Resistant (XDR) Acinetobacter baumannii from a Tertiary Hospital in Greece. Med. Sci. Forum, 12.","DOI":"10.3390\/antibiotics12010093"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mantzana, P., Protonotariou, E., Kassomenaki, A., Meletis, G., Tychala, A., Keskilidou, E., Arhonti, M., Katsanou, C., Daviti, A., and Vasilaki, O. (2023). In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae. Antibiotics, 12.","DOI":"10.3390\/antibiotics12010093"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Palombo, M., Bovo, F., Amadesi, S., and Gaibani, P. (2023). Synergistic Activity of Cefiderocol in Combination with Piperacillin-Tazobactam, Fosfomycin, Ampicillin-Sulbactam, Imipenem-Relebactam and Ceftazidime-Avibactam against Carbapenem-Resistant Gram-Negative Bacteria. Antibiotics, 12.","DOI":"10.3390\/antibiotics12050858"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wang, J., Stegger, M., Moodley, A., and Yang, M. (2023). Drug Combination of Ciprofloxacin and Polymyxin B for the Treatment of Multidrug\u2013Resistant Acinetobacter baumannii Infections: A Drug Pair Limiting the Development of Resistance. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030720"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Luna-De-Alba, A., Flores-Trevi\u00f1o, S., Camacho-Ortiz, A., Contreras-Cordero, J.F., and Bocanegra-Ibarias, P. (2024). Genetic Characterization of Multidrug-Resistant Acinetobacter baumannii and Synergy Assessment of Antimicrobial Combinations. Antibiotics, 13.","DOI":"10.3390\/antibiotics13111079"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lewis, R.E., Palombo, M., Diani, E., Secci, B., Gibellini, D., and Gaibani, P. (2024). Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria. Cells, 13.","DOI":"10.3390\/cells13161315"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"106344","DOI":"10.1016\/j.ijantimicag.2021.106344","article-title":"Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli","volume":"57","author":"Scudeller","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1378\/chest.14-2171","article-title":"Antimicrobial resistance in hospital-acquired gram-negative bacterial infections","volume":"147","author":"Mehrad","year":"2015","journal-title":"Chest"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41429-022-00573-z","article-title":"In vitro analysis of synergistic combination of polymyxin B with 12 other antibiotics against MDR Acinetobacter baumannii isolated from a Chinese tertiary hospital","volume":"76","author":"Liu","year":"2023","journal-title":"J. Antibiot."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jmii.2024.01.009","article-title":"Comparison of in vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrug-resistant Acinetobacter baumannii isolates","volume":"57","author":"Wang","year":"2024","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijmmb.2021.04.006","article-title":"In vitro synergistic effect of colistin and ampicillin\/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii","volume":"39","author":"Shafiee","year":"2021","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Marino, A., Augello, E., Stracquadanio, S., Bellanca, C.M., Cosentino, F., Spampinato, S., Cantarella, G., Bernardini, R., Stefani, S., and Cacopardo, B. (2024). Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25136814"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Rodjun, V., Houngsaitong, J., Montakantikul, P., Paiboonvong, T., Khuntayaporn, P., Yanyongchaikit, P., and Sriyant, P. (2020). In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant Acinetobacter baumannii Using the Broth Microdilution Checkerboard and Time-Kill Methods. Antibiotics, 9.","DOI":"10.3390\/antibiotics9080516"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1039\/D3PM00014A","article-title":"Dextrin conjugation to colistin inhibits its toxicity, cellular uptake and acute kidney injury in vivo","volume":"1","author":"Varache","year":"2024","journal-title":"RSC Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gaudereto, J.J., Neto, L.V.P., Leite, G.C., Espinoza, E.P.S., Martins, R.C.R., Villas Boa Prado, G., Rossi, F., Guimar\u00e3es, T., Levin, A.S., and Costa, S.F. (2020). Comparison of methods for the detection of in vitro synergy in multidrug-resistant gram-negative bacteria. BMC Microbiol., 20.","DOI":"10.1186\/s12866-020-01756-0"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Quraini, M.A., Jabri, Z.A., Sami, H., Mahindroo, J., Taneja, N., Muharrmi, Z.A., Busaidi, I.A., and Rizvi, M. (2023). Exploring Synergistic Combinations in Extended and Pan-Drug Resistant (XDR and PDR) Whole Genome Sequenced Acinetobacter baumannii. Microorganisms, 11.","DOI":"10.3390\/microorganisms11061409"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Wences, M., Wolf, E.R., Li, C., Singh, N., Bah, N., Tan, X., Huang, Y., and Bulman, Z.P. (2022). Combatting Planktonic and Biofilm Populations of Carbapenem-Resistant Acinetobacter baumannii with Polymyxin-Based Combinations. Antibiotics, 11.","DOI":"10.3390\/antibiotics11070959"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Black, C., Al Mahmud, H., Howle, V., Wilson, S., Smith, A.C., and Wakeman, C.A. (2023). Development of a Polymicrobial Checkerboard Assay as a Tool for Determining Combinatorial Antibiotic Effectiveness in Polymicrobial Communities. Antibiotics, 12.","DOI":"10.3390\/antibiotics12071207"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/6\/1206\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:40:03Z","timestamp":1760031603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/13\/6\/1206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["microorganisms13061206"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms13061206","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]}}}